Literature DB >> 15238214

Expression and induction of CYP4F subfamily in human leukocytes and HL60 cells.

Yasushi Kikuta1, Yoshiaki Yamashita, Soichiro Kashiwagi, Kazunori Tani, Kazushi Okada, Kiyofumi Nakata.   

Abstract

We investigated the expression of the CYP4F subfamily in human leukocytes and HL60 cells. Enzymatic activity assay, immunocytochemical staining, and reverse transcription-polymerase chain reaction (RT-PCR) analysis of human leukocytes showed that polymorphonuclear leukocytes (PMNs) expressed CYP4F3B and CYP4F12 in addition to CYP4F3. Transcription start site of CYP4F3B mRNA in the leukocytes was identical to that of CYP4F3 mRNA. The HL60 cells, which were differentiated into PMN-like shapes by treatment with all-trans-retinoic acid (RA), also expressed CYP4F3, CYP4F3B and CYP4F12. CYP4F3 was expressed in one third of the peripheral monocytes, which omega-hydroxylated leukotriene B(4) (LTB(4)) at a rate 11 times lower than that of PMN. The cells that were differentiated into a form similar to monocytes/macrophages in shape by treatment with 12-myristate 13-acetate expressed mRNA for CYP4F3 and CYP4F3B. Promoter analysis of the CYP4F3 gene demonstrated that a region (-174/-90) of this gene was important for its promoter activity in the HL60 cells. This is the first report on the distribution of different CYP4F isoforms in leukocytes and their induction in HL60 cells.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15238214     DOI: 10.1016/j.bbalip.2004.03.007

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  7 in total

Review 1.  Role of cytochrome P450 activity in the fate of anticancer agents and in drug resistance: focus on tamoxifen, paclitaxel and imatinib metabolism.

Authors:  Bertrand Rochat
Journal:  Clin Pharmacokinet       Date:  2005       Impact factor: 6.447

2.  Altered leukotriene B4 metabolism in CYP4F18-deficient mice does not impact inflammation following renal ischemia.

Authors:  Valeria Winslow; Rachel Vaivoda; Aleksandr Vasilyev; David Dombkowski; Karim Douaidy; Christopher Stark; Justin Drake; Evin Guilliams; Dharamainder Choudhary; Frederic Preffer; Ivaylo Stoilov; Peter Christmas
Journal:  Biochim Biophys Acta       Date:  2014-03-14

3.  Elevated 20-HETE in metabolic syndrome regulates arterial stiffness and systolic hypertension via MMP12 activation.

Authors:  Amanda Soler; Ian Hunter; Gregory Joseph; Rebecca Hutcheson; Brenda Hutcheson; Jenny Yang; Frank Fan Zhang; Sachindra Raj Joshi; Chastity Bradford; Katherine H Gotlinger; Rachana Maniyar; John R Falck; Spencer Proctor; Michal Laniado Schwartzman; Sachin A Gupte; Petra Rocic
Journal:  J Mol Cell Cardiol       Date:  2018-02-08       Impact factor: 5.000

4.  Cytotoxic 1-deoxysphingolipids are metabolized by a cytochrome P450-dependent pathway.

Authors:  Irina Alecu; Alaa Othman; Anke Penno; Essa M Saied; Christoph Arenz; Arnold von Eckardstein; Thorsten Hornemann
Journal:  J Lipid Res       Date:  2016-11-21       Impact factor: 5.922

5.  Maresin-like lipid mediators are produced by leukocytes and platelets and rescue reparative function of diabetes-impaired macrophages.

Authors:  Song Hong; Yan Lu; Haibin Tian; Bhagwat V Alapure; Quansheng Wang; Bruce A Bunnell; James Monroe Laborde
Journal:  Chem Biol       Date:  2014-09-04

6.  Catalytic characterization and cytokine mediated regulation of cytochrome P450 4Fs in rat hepatocytes.

Authors:  Auinash Kalsotra; Sayeepriyadarshini Anakk; Chad L Brommer; Yasushi Kikuta; Edward T Morgan; Henry W Strobel
Journal:  Arch Biochem Biophys       Date:  2007-03-15       Impact factor: 4.013

7.  20-Hydroxylation is the CYP-dependent and retinoid-inducible leukotriene B4 inactivation pathway in human and mouse skin cells.

Authors:  Liping Du; Huiyong Yin; Jason D Morrow; Henry W Strobel; Diane S Keeney
Journal:  Arch Biochem Biophys       Date:  2009-01-20       Impact factor: 4.013

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.